Problem statement: Answer the multiple choice question.
Query: Which drug exhibits a 18.089\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a.) CCOc1ccc(C(CC(=O)O)NC(=O)C23CC4CC(CC(C4)C2)C3)cc1OC
b.) CC(C)NC(=O)c1ccc(COCC(F)(F)F)cc1
c.) CCSc1nnc(NC(=O)CC)s1
Answer: b. CC(C)NC(=O)c1ccc(COCC(F)(F)F)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC(C)NC(=O)c1ccc(COCC(F)(F)F)cc1
CC(C)NC(=O)c1ccc(COCC(F)(F)F)cc1
N-propan-2-yl-4-(2,2,2-trifluoroethoxymethyl)benzamide